ChiCTR2200055513 版本V2.3 版本创建时间2022/07/29 10:11:20 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2200055513 

最近更新日期:

Date of Last Refreshed on:

2022-07-29 10:11:04 

注册时间:

Date of Registration:

2022-01-11 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

请于伦理委员会批准后才开始征募参试者,并与我们联系上传伦理批件 慢性疲劳综合征药食同源组方的效果观察

Public title:

An observation study of the effect of homologous prescription of medicine and food on chronic fatigue syndrome

注册题目简写:

English Acronym:

研究课题的正式科学名称:

慢性疲劳综合征药食同源组方的效果观察

Scientific title:

An observation study of the effect of homologous prescription of medicine and food on chronic fatigue syndrome

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

ChiMCTR2200005527

申请注册联系人:

姚志翠 

研究负责人:

骆彬 

Applicant:

Yao Zhicui 

Study leader:

Luo Bin 

申请注册联系人电话:

Applicant telephone:

+86 15931175599

研究负责人电话:

Study leader's
telephone:

+86 18633889869

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

sjzwxyzc@163.com

研究负责人电子邮件:

Study leader's E-mail:

luobinyisheng@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

河北省石家庄市东岗路89号

研究负责人通讯地址:

河北省石家庄市东岗路89号

Applicant address:

89 Donggang Road, Shijiazhuang, Hebei

Study leader's address:

89 Donggang Road, Shijiazhuang, Hebei

申请注册联系人邮政编码:

Applicant postcode:

050031

研究负责人邮政编码:

Study leader's postcode:

050031

申请人所在单位:

河北医科大学第一医院

Applicant's institution:

the First Hospital of Hebei Medical University

研究负责人所在单位:

河北医科大学第一医院

Affiliation of the Leader:

the First Hospital of Hebei Medical University

是否获伦理委员会批准:

Approved by ethic committee:

No

伦理委员会批件文号:

Approved No. of ethic committee:

伦理委员会批件附件:

Approved file of Ethical Committee:

批准本研究的伦理委员会名称:

Name of the ethic committee:

伦理委员会批准日期:

Date of approved by ethic committee:

2013-08-26 00:00:00

伦理委员会联系人:

Contact Name of the ethic committee:

伦理委员会联系地址:

Contact Address of the ethic committee:

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

河北中医学院

Primary sponsor:

Hebei College of Traditional Chinese Medicine

研究实施负责(组长)单位地址:

河北省石家庄市东岗路89号

Primary sponsor's address:

89 Donggang Road, Shijiazhuang, Hebei

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

河北

市(区县):

石家庄

Country:

China

Province:

Hebei

City:

Shijiazhuang

单位(医院):

河北医科大学第一医院

具体地址:

东岗路89号

Institution
hospital:

the First Hospital of Hebei Medical University

Address:

89 Donggang Road

经费或物资来源:

河北省中医药管理局科研计划项目

Source(s) of funding:

Scientific Research Project of Hebei Administration of Traditional Chinese Medicine

研究疾病:

慢性疲劳综合征  

Target disease:

chronic fatigue syndrome

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

1. 观察药食同源组方对慢性疲劳综合征患者的干预效果; 2. 改善患者生活质量,降低医疗成本。  

Objectives of Study:

1. To observe the intervention effect of medicine and food homology prescription on patients with chronic fatigue syndrome; 2. To improve the quality of life of patients and reduce medical cost.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1. 使用美国疾病预防控制中心标准诊断为CFS的18-65岁男性或女性参与者;
根据CDC标准,CFS患者必须表现出以下症状:
(1)连续6个月或更长时间持续或反复出现疲劳,这与持续劳累或其他与疲劳有关的医疗状况无关;
(2)明显干扰个人活动的疲劳和工作;
(3)四个或更多并发症状(短期记忆或注意力集中受损;喉咙痛;颈或腋窝淋巴结压痛;肌肉疼痛;无关节肿胀或发红的多关节疼痛;新型头痛,或严重程度;不清醒的睡眠;以及运动后不适持续超过24小时)。
2. 近1个月内未接受过任何针对CFS的治疗;
3. 自愿提供签署的同意书。

Inclusion criteria

1. Male or female participants, aged 18 to 65 years who were diagnosed with CFS according to CDC criteria;
According to CDC standards, CFS patients must show the following symptoms:
(1) Persistent or recurrent fatigue for 6 months or more, not related to persistent fatigue or any other medical condition related to fatigue;
(2) Fatigue and work that significantly interferes with personal activities;
(3) Four or more concurrent symptoms (impaired short-term memory or concentration; sore throat; tenderness of cervical or axillary lymph nodes; muscle pain; multiple joint pain without joint swelling or redness; new headache, or severity; unawake sleep; and discomfort lasting more than 24 hours after exercise).
2. Have not received any treatment for CFS in the past 1 month;
3. Voluntarily signed consent forms.

排除标准:

1.妊娠或哺乳期妇女;
2.病前2年至今有各种不良嗜好,嗜烟、酗酒等;
3.合并心、肝、肾、脑等脏器功能不全或精神病患者;
4.原发性或器质性疾病导致的慢性疲劳患者;
5.过度肥胖者(体质量指数≥45);
6.在试验前3个月内参加其他临床试验;
7.过敏体质或对中药已知成分过敏者。

Exclusion criteria:

1. Pregnant or lactating women;
2. All kinds of bad habits, such as smoking and drinking within 2 years before the disease;
3. Patients with heart, liver, kidney, brain and other organ dysfunction or mental illness;
4. Patients with chronic fatigue caused by primary or organic diseases;
5. Obese (BMI >= 45);
6. Participate in other clinical trials within 3 months prior to the trial;
7. Allergic constitution or allergic to known ingredients of traditional Chinese medicine.

研究实施时间:

Study execute time:

From 2022-01-17 00:00:00 To 2022-01-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2022-01-07 00:00:00 To 2022-01-15 00:00:00

干预措施:

Interventions:

组别:

对照组

样本量:

40

Group:

The control group

Sample size:

干预措施:

健康教育

干预措施代码:

Intervention:

Health education

Intervention code:

组别:

试验组

样本量:

40

Group:

The experimental group

Sample size:

干预措施:

药食同源组方

干预措施代码:

Intervention:

Homologous medicine and food recipe

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

河北 

市(区县):

石家庄 

Country:

China

Province:

Hebei

City:

Shijiazhuang

单位(医院):

河北医科大学第一医院 

单位级别:

三级甲等 

Institution
hospital:

the First Hospital of Hebei Medical University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

一般情况调查表

指标类型:

主要指标

Outcome:

General information questionnaire

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

健康状况调查问卷(SF-36)

指标类型:

主要指标

Outcome:

The Short-Form (SF-36) Health Survey

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

疲劳症状

指标类型:

主要指标

Outcome:

Symptoms of fatigue

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

疲劳严重程度量表(FSS)

指标类型:

主要指标

Outcome:

Fatigue severity scale, FSS

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

N/A

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 65 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

随机数字

Randomization Procedure (please state who generates the random number sequence and by what method):

Random number

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

未说明

Blinding:

Not stated

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

N/A

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

N/A

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2022-01-11 05:06:21